An approach to proteomic analysis of human tumors
β Scribed by Michael R. Emmert-Buck; John W. Gillespie; Cloud P. Paweletz; David K. Ornstein; Venkatesha Basrur; Ettore Appella; Quan-Hong Wang; Jing Huang; Nan Hu; Phil Taylor; Emanuel F. Petricoin III
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 189 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
β¦ Synopsis
A strategy for proteomic analysis of microdissected cells derived from human tumor specimens is described and demonstrated by using esophageal cancer as an example. Normal squamous epithelium and corresponding tumor cells from two patients were procured by laser-capture microdissection and studied by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE). Fifty thousand cells resolved approximately 675 distinct proteins (or isoforms) with molecular weights ranging between 10 and 200 kDa and isoelectric points of pH 3Β±10. Comparison of the microdissected protein profiles showed a high degree of similarity between the matched normal-tumor samples (98% identical). However, 17 proteins showed tumor-specific alterations, including 10 that were uniquely present in the tumors and seven that were observed only in the normal epithelium. Two of the altered proteins were characterized by mass spectrometry and immunoblot analysis and were identified as cytokeratin 1 and annexin I. Acquisition of 2D-PAGE protein profiles, visualization of disregulated proteins, and subsequent determination of the identity of selected proteins through high-sensitivity MS-MS microsequencing are possible from microdissected cell populations. These separation and analytical techniques are uniquely capable of detecting tumor-specific alterations. Continued refinement of techniques and methodologies to determine the abundance and status of proteins in vivo holds great promise for future study of normal cells and associated neoplasms. Mol.
π SIMILAR VOLUMES
## Contribution of proteomics to tumor immunology In the postgenome era, the global analysis of gene and protein expression is allowed at RNA and protein level by microarrays and proteomics. The application of these complementary approaches provides new opportunities for tumor immunology investiga
Bovine hereditary dilated cardiomyopathy (bCMP) is endemic in Switzerland and hearts from diseased animals display important clinical and biochemical similarities to human DCM. Recent research has identified at least one protein (myoglobin) to be significantly reduced in bovine DCM. Using a proteomi